Next Article in Journal
Oxytocin, a Novel Treatment for Methamphetamine Use Disorder
Next Article in Special Issue
Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach
Previous Article in Journal
Acknowledgment to Reviewers of Neurology International in 2021
Previous Article in Special Issue
Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection
 
 
Case Report

Article Versions Notes

Neurol. Int. 2022, 14(1), 176-185; https://doi.org/10.3390/neurolint14010014
Action Date Notes Link
article xml file uploaded 28 January 2022 11:59 CET Original file -
article xml uploaded. 28 January 2022 11:59 CET Update -
article pdf uploaded. 28 January 2022 11:59 CET Version of Record -
article html file updated 28 January 2022 12:00 CET Original file -
article html file updated 28 January 2022 12:00 CET Update -
article xml file uploaded 28 January 2022 12:13 CET Update -
article xml uploaded. 28 January 2022 12:13 CET Update https://www.mdpi.com/2035-8377/14/1/14/xml
article pdf uploaded. 28 January 2022 12:13 CET Updated version of record https://www.mdpi.com/2035-8377/14/1/14/pdf
article html file updated 28 January 2022 12:15 CET Update -
article html file updated 31 July 2022 07:17 CEST Update https://www.mdpi.com/2035-8377/14/1/14/html
Back to TopTop